|
Roderick L. Mackenzie, joined PhytoCeutica in 2007. Prior to joining PhytoCeutica, Mr. Mackenzie had been associated with the Johnson and Johnson family of companies for many years in Canada and the United States. Most recently he had served as President of Ortho Pharmaceutical Corporation of Raritan, New Jersey and Vice President of Johnson and Johnson International, New Brunswick, New Jersey. Prior to that Mr. Mackenzie was President of Johnson and Johnson Dental Products of East Windsor, New Jersey. Before moving to New Jersey in 1973 Mr. Mackenzie was President of Ortho Pharmaceutical and Ortho Diagnostics in Toronto, Canada. He has founded and chaired two healthcare related companies, Gynetics, Inc., which was sold to Barr Laboratories in 2002, and GynoPharma Inc., which was sold to Ortho-McNeil Pharmaceutical, a Johnson and Johnson company in 1995. Mr. Mackenzie has a Bachelor of Science degree in Chemical Engineering from the University of Saskatchewan in Canada and completed the Advanced Management Program of the Columbia University Graduate School of Business. | 